Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Emergency funding for COVID-19 studies not requiring clinical trials

Date added: 05 May 2020

Projects should carry out on rapid research into fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures.

Amount
Up to $275.000 (USD)
Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Higher education institutions, non-profit organisations, SMEs, for-profit organisations, governments

Foreign participation? (where known)
Yes

Emergency competitive revisions for research on SARS-CoV-2 and COVID-19

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Existing NIAID grantholders

Date application deadline

Existing calls welcome proposals to develop medical countermeasures against SARS-CoV-2/COVID-19

Date added: 23 Apr 2020

NIAID announces that a number of existing calls will particularly welcome research objectives related to pathogenicity, transmission, medical countermeasures, pre-clinical testing of vaccines and therapeutics.

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Date application deadline